| Year |
Citation |
Score |
| 2013 |
Vojvodic M, Hansford LM, Morozova O, Blakely KM, Taylor P, Fathers KE, Moffat J, Marra M, Smith KM, Moran MF, Kaplan DR. A phosphoproteomics approach to identify candidate kinase inhibitor pathway targets in lymphoma-like primary cell lines. Current Drug Discovery Technologies. 10: 283-304. PMID 23701117 DOI: 10.2174/15701638113109990001 |
0.491 |
|
| 2011 |
Mak AB, Blakely KM, Williams RA, Penttilä PA, Shukalyuk AI, Osman KT, Kasimer D, Ketela T, Moffat J. CD133 protein N-glycosylation processing contributes to cell surface recognition of the primitive cell marker AC133 epitope. The Journal of Biological Chemistry. 286: 41046-56. PMID 21937449 DOI: 10.1074/Jbc.M111.261545 |
0.501 |
|
| 2011 |
Blakely K, Ketela T, Moffat J. Pooled lentiviral shRNA screening for functional genomics in mammalian cells. Methods in Molecular Biology (Clifton, N.J.). 781: 161-82. PMID 21877282 DOI: 10.1007/978-1-61779-276-2_9 |
0.547 |
|
| 2011 |
Ketela T, Heisler LE, Brown KR, Ammar R, Kasimer D, Surendra A, Ericson E, Blakely K, Karamboulas D, Smith AM, Durbic T, Arnoldo A, Cheung-Ong K, Koh JL, Gopal S, et al. A comprehensive platform for highly multiplexed mammalian functional genetic screens. Bmc Genomics. 12: 213. PMID 21548937 DOI: 10.1186/1471-2164-12-213 |
0.527 |
|
| 2010 |
Smith KM, Datti A, Fujitani M, Grinshtein N, Zhang L, Morozova O, Blakely KM, Rotenberg SA, Hansford LM, Miller FD, Yeger H, Irwin MS, Moffat J, Marra MA, Baruchel S, et al. Selective targeting of neuroblastoma tumour-initiating cells by compounds identified in stem cell-based small molecule screens. Embo Molecular Medicine. 2: 371-84. PMID 20721990 DOI: 10.1002/Emmm.201000093 |
0.521 |
|
| 2010 |
Morozova O, Vojvodic M, Grinshtein N, Hansford LM, Blakely KM, Maslova A, Hirst M, Cezard T, Morin RD, Moore R, Smith KM, Miller F, Taylor P, Thiessen N, Varhol R, et al. System-level analysis of neuroblastoma tumor-initiating cells implicates AURKB as a novel drug target for neuroblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 4572-82. PMID 20651058 DOI: 10.1158/1078-0432.Ccr-10-0627 |
0.526 |
|
| 2010 |
Mak AB, Ni Z, Hewel JA, Chen GI, Zhong G, Karamboulas K, Blakely K, Smiley S, Marcon E, Roudeva D, Li J, Olsen JB, Wan C, Punna T, Isserlin R, et al. A lentiviral functional proteomics approach identifies chromatin remodeling complexes important for the induction of pluripotency. Molecular & Cellular Proteomics : McP. 9: 811-23. PMID 20305087 DOI: 10.1074/Mcp.M000002-Mcp201 |
0.483 |
|
| 2010 |
Hansford LM, Morozova O, Lipman T, Blakely K, Ohira M, Marrano P, Angelini P, Moffat J, Thiele CJ, Thorner P, Dick J, Nakagawara A, Irwin M, Marra M, Kaplan DR. Abstract 12: Metastatic neuroblastoma cancer stem cells display a mixed phenotype of tumor and niche origin required for survival Cancer Research. 70: 12-12. DOI: 10.1158/1538-7445.Am10-12 |
0.504 |
|
| Show low-probability matches. |